✦ LIBER ✦

Losartan and E3174 Pharmacokinetics in Cytochrome P450 2C91/1, 1/2, and 1/3 Individuals

✍ Scribed by Craig R. Lee; John A. Pieper; Alan L. Hinderliter; Joyce A. Blaisdell; Joyce A. Goldstein

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differences in flurbiprofen pharmacokine

✍ Craig R. Lee; John A. Pieper; Reginald F. Frye; Alan L. Hinderliter; Joyce A. Bl 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 200 KB

Cytochromes P450 2C1/2 and P450 2E1 Are

✍ Elzbieta Szczesna-Skorupa; Ci-Di Chen; Byron Kemper 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 368 KB

Different Contributions of Cytochrome P4

✍ T. Nakajima; E. Elovaara; T. Okino; H.V. Gelboin; M. Klockars; V. Riihimaki; T. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 698 KB

Cytochrome P450 2A1, 2E1, and 2C9 cDNA-e

✍ James Grogan; Magang Shou; Ericka A. Andrusiak; Shinji Tamura; Jeroen T.M. Buter 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 906 KB

Expression and distribution of cytochrom

✍ Laura N. Healy; Linda J. Pluta; Leslie Recio 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 432 KB

Mechanism-Based Inactivation of Cytochro

✍ Elizabeth S. Roberts; William L. Alworth; Paul F. Hollenberg 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Losartan and E3174 Pharmacokinetics in Cytochrome P450 2C9*1/*1, *1/*2, and *1/*3 Individuals